The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Easom Eric since 2022.
This trader's CIK number is 1914503.
At the time of last reporting, Easom Eric was the Chief Executive Officer of An2 Therapeutics, Inc.. (stock ticker symbol ANTX).
Also see all insider trading activities at An2 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ANTX | 10,000 | $10,670 | 0 | $0 | 0 | $0 |
| 2024 | ANTX | 50,000 | $49,950 | 2,777 | $55,803 | 0 | $0 |
| 2023 | ANTX | 10,000 | $53,770 | 0 | $0 | 0 | $0 |
| 2022 | ANTX | 0 | $0 | 94,231 | $1,506,875 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-06-02 | ANTX | Buy | 10,000 | 1.07 | 10,670 |
| 2024-11-18 | ANTX | Buy | 50,000 | 1.00 | 49,950 |
| 2024-01-02 | ANTX | Sale | 2,777 | 20.09 | 55,803 |
| 2023-05-15 | ANTX | Buy | 10,000 | 5.38 | 53,770 |
| 2022-11-14 | ANTX | Sale | 23 | 15.04 | 345 |
| 2022-11-10 | ANTX | Sale | 4,413 | 15.32 | 67,629 |
| 2022-11-08 | ANTX | Sale | 7,055 | 15.90 | 112,153 |
| 2022-11-09 | ANTX | Sale | 10,111 | 15.61 | 157,842 |
| 2022-11-03 | ANTX | Sale | 14,165 | 15.84 | 224,430 |
| 2022-11-04 | ANTX | Sale | 8,828 | 15.80 | 139,473 |
| 2022-11-07 | ANTX | Sale | 12,203 | 16.31 | 199,043 |
| 2022-10-31 | ANTX | Sale | 2,688 | 15.39 | 41,362 |
| 2022-11-02 | ANTX | Sale | 1,544 | 15.07 | 23,261 |
| 2022-10-27 | ANTX | Sale | 924 | 15.36 | 14,189 |
| 2022-10-28 | ANTX | Sale | 1,683 | 15.09 | 25,393 |
| 2022-10-26 | ANTX | Sale | 1,678 | 15.10 | 25,342 |
| 2022-10-25 | ANTX | Sale | 4,806 | 15.95 | 76,631 |
| 2022-10-24 | ANTX | Sale | 2,866 | 16.17 | 46,343 |
| 2022-10-20 | ANTX | Sale | 7,293 | 16.91 | 123,346 |
| 2022-10-21 | ANTX | Sale | 13,951 | 16.49 | 230,093 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Easom Eric (Chief Executive Officer of An2 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.